주식/증권
➡️ 중립
관련 뉴스
NeuroPace expects ~15% RNS growth in 2027 as it revises 2026 revenue guidance to $91M-$92M
11/13/2026
Cibus targets biofragrance peak revenue up to $100M while aiming for rice launch as early as 2028
11/13/2026
Cytosorbents outlines early 2027 DrugSorb-ATR De Novo plan with $300M initial U.S./Canada market
11/13/2026
Cisco outlines FY 2027 revenue of $74.8B-$75.8B as it projects $9B in hyperscaler AI infrastructure revenue
11/13/2026